Farallon Capital Management LLC Bridge Bio Pharma, Inc. Transaction History
Farallon Capital Management LLC
- $22.3 Billion
- Q2 2025
A detailed history of Farallon Capital Management LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 7,900,000 shares of BBIO stock, worth $405 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
7,900,000Holding current value
$405 Million% of portfolio
1.53%Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
188MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$950 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$844 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$679 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$637 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$475 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.59B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...